On 2014 Feb 08, Jenny Doust commented:

An interesting trial which shows that moving to an absolute risk approach for cardiovascular disease prevention is probably more difficult than first thought. The study also shows two things not obvious in the abstract: 1) The problem of overprescribing to patients at low risk of a cardiovascular is a much larger problem than underprescribing to patients at high risk (in this study about 25% of the low risk patients were taking blood pressure or lipid lowering medication which was about 150 people, compared with about the same percentage of patients at high risk not taking either blood pressure or lipid lowering but this is 5 people) 2) The intervention was effective in reducing prescribing of blood pressure lowering medication to patients at low risk - see Figure 2.

On 2014 Feb 08, Jenny Doust commented:

An interesting trial which shows that moving to an absolute risk approach for cardiovascular disease prevention is probably more difficult than first thought. The study also shows two things not obvious in the abstract: 1) The problem of overprescribing to patients at low risk of a cardiovascular is a much larger problem than underprescribing to patients at high risk (in this study about 25% of the low risk patients were taking blood pressure or lipid lowering medication which was about 150 people, compared with about the same percentage of patients at high risk not taking either blood pressure or lipid lowering but this is 5 people) 2) The intervention was effective in reducing prescribing of blood pressure lowering medication to patients at low risk - see Figure 2.